| Together for Rare Diseases & ERICA Webinar | 2025-01-16 | 17:00 – 17:45 hr | | | |
| Together for Rare Diseases & ERICA Webinar about ERNs for Industry partners | 2024-12-02 | 17:00 – 17:45 hr | Alberto Pereira, Franz Schäfer, Katarzyna Mosiewicz and Sheela Upadhyaya | | |
| Disease Specific Measures | 2024-07-24 | 15:00 – 16:30 hr | Tanja Wlodkowski, Faisal Ahmed, Ana Priego Zurita and Johan de Graaf | | |
| c4c expert advice, patient and public involvement, data standards | 2024-05-03 | 13:00 – 14:00 hr | Mark Turner, Fenna Mahler , Pamela Dicks and Becca Leary | | |
| Approaches to the Evaluation of Evidence for Rare Disease and Complex Conditions Guidelines | 2024-04-29 | 14:00 – 15:30 hr | | | |
| c4c trials, education and training | 2024-04-11 | 13:00 – 14:00 hr | Mark Turner, Chloe Bickerstaff , Francesca Rocchi and Becca Leary | | |
| EMA Webinar on Rare World Diseases Day | 2024-02-29 | 16:00 – 17:25 hr | Kristina Larsson, Virginie Hivert , Melanie Carr , Hélène Le Borgne, Theodor Framke, Violeta Stoyanova-Beninska, Iordanis Gravanis, Maria Mavris and Maribel Rico-Salas | | |
| Transitioning trials to the CTR (CTIS) for non-commercial sponsors | 2024-02-09 | 10:00 – 13:00 hr | | | |
| “Bridging the gap between promising preclinical data and a successful clinical trial” | 2023-10-19 | 16:00 – 17:00 hr | Gilles Vassal and Joanne Lee | | |
| REMEDI4ALL / drug repurposing and clinical trial readiness by Anton Ussi | 2023-10-02 | 13:00 – 14:00 hr | Anton Ussi | | |
| Framework for Patient Engagement in Clinical Trials | 2023-05-24 | 15:00 – 16:00 hr | Virginie Hivert and María Cavaller Bellaubi | | |
| Introduction on Patient-Reported Outcomes and considerations before including them in a clinical trial. Study case from the ERN-EuroBloodNet | 2023-05-10 | 12:30 – 13:30 hr | Céline Desvignes-Gleizes, Andreas Glenthøj and Dore Peereboom | | |
| Designing and conducting clinical trials in rare diseases – what industries expect for partnering with clinical sites | 2023-04-14 | 12:30 – 13:30 hr | Diego Ardigò | | |
| Definition of orphan drug by the EMA | 2023-03-28 | 12:30 – 13:30 hr | Armando Magrelli | | |
| Essential requirements before thinking about a clinical trial | 2023-02-28 | 12:00 – 13:00 hr | Viviana Giannuzzi | | |
| Joint HMA/EMA Multi-stakeholder workshop on Patient Registries 12&13 February 2024 | 2023-02-12 | | | | |
| WP5 Educational Webinar 2 “Practical guide on how to use the Catalogue of services and the IMT” | 2022-10-24 | 13:00 – 14:00 hr | Anton Ussi, Agustin Arasanz Duque and Rosan Vegter | | |
| Composite endpoints including patient relevant endpoints (Quality of Life) | 2022-05-06 | 16:00 – 18:30 hr | Johan Verbeeck | | |
| EMA Virtual meeting Repurposing ‘WALK-IN’ CLINIC | 2022-02-17 | 17:00 – 18:30 hr | | | |
| Does Randomization matter in RD clinical trials? | 2021-12-14 | | Ralf-Dieter Hilgers | | |
| EMA Webinar for SMEs and Academia on the Clinical Trials Regulation and the Clinical Trials Information System | 2021-11-29 | 9:00 – 13:30 hr | | | |
| Educational Webinar 1 Current research services available for the rare diseases community | 2021-11-08 | 15:00 – 16:00 hr | Anton Ussi | | |